Literature DB >> 28811625

Interleukin-7 in the transition of bone marrow progenitors to the thymus.

Adam W Plumb1, Abdalla Sheikh1, Douglas A Carlow2, Daniel T Patton1, Hermann J Ziltener2, Ninan Abraham1,3.   

Abstract

Interleukin-7 (IL-7) is essential for the development of T cells in humans and mice where deficiencies in IL-7 signaling result in severe immunodeficiency. T cells require IL-7 at multiple points during development; however, it is unclear when IL-7 is first necessary. We observed that mice with impaired IL-7 signaling had a large reduction in the number of early thymic progenitors (ETPs) while mice that overexpress IL-7 had greatly increased numbers of ETPs. These results indicated that the development of ETPs is sensitive to IL-7. Bone marrow progenitors of ETP are present in normal numbers in mice with impaired IL-7 signaling (IL-7Rα449F) and were efficiently recruited to the thymus. Furthermore, ETPs and their progenitors from IL-7Rα449F mice did not undergo increased apoptosis and proliferate normally compared to WT cells. Mixed bone marrow chimeras demonstrated that IL-7 signaling has a cell-intrinsic role in ETP development but was not required for development of bone marrow progenitors. We have shown a novel role for IL-7 signaling in the development of ETPs that is distinct from classic mechanisms of IL-7 regulating survival and proliferation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28811625     DOI: 10.1038/icb.2017.68

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  48 in total

1.  Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors.

Authors:  C Pallard; A P Stegmann; T van Kleffens; F Smart; A Venkitaraman; H Spits
Journal:  Immunity       Date:  1999-05       Impact factor: 31.745

Review 2.  Transcriptional control of early T and B cell developmental choices.

Authors:  Ellen V Rothenberg
Journal:  Annu Rev Immunol       Date:  2014-01-22       Impact factor: 28.527

3.  IL-7 mediates Ebf-1-dependent lineage restriction in early lymphoid progenitors.

Authors:  Panagiotis Tsapogas; Sasan Zandi; Josefine Åhsberg; Jenny Zetterblad; Eva Welinder; Jan Ingvar Jönsson; Robert Månsson; Hong Qian; Mikael Sigvardsson
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

4.  Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.

Authors:  Miguel-Angel Perales; Jenna D Goldberg; Jianda Yuan; Guenther Koehne; Lauren Lechner; Esperanza B Papadopoulos; James W Young; Ann A Jakubowski; Bushra Zaidi; Humilidad Gallardo; Cailian Liu; Teresa Rasalan; Jedd D Wolchok; Therese Croughs; Michel Morre; Sean M Devlin; Marcel R M van den Brink
Journal:  Blood       Date:  2012-09-25       Impact factor: 22.113

5.  Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas.

Authors:  Ninan Abraham; Melissa C Ma; Jonathan W Snow; Melissa Jill Miners; Brian G Herndier; Mark A Goldsmith
Journal:  Oncogene       Date:  2005-08-04       Impact factor: 9.867

6.  Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.

Authors:  Priscila P Zenatti; Daniel Ribeiro; Wenqing Li; Linda Zuurbier; Milene C Silva; Maddalena Paganin; Julia Tritapoe; Julie A Hixon; André B Silveira; Bruno A Cardoso; Leonor M Sarmento; Nádia Correia; Maria L Toribio; Jörg Kobarg; Martin Horstmann; Rob Pieters; Silvia R Brandalise; Adolfo A Ferrando; Jules P Meijerink; Scott K Durum; J Andrés Yunes; João T Barata
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

7.  Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies.

Authors:  Marc Pellegrini; Thomas Calzascia; Alisha R Elford; Arda Shahinian; Amy E Lin; Dilan Dissanayake; Salim Dhanji; Linh T Nguyen; Matthew A Gronski; Michel Morre; Brigitte Assouline; Katharina Lahl; Tim Sparwasser; Pamela S Ohashi; Tak W Mak
Journal:  Nat Med       Date:  2009-04-26       Impact factor: 53.440

8.  Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7R alpha mutant mice.

Authors:  Lisa C Osborne; Salim Dhanji; Jonathan W Snow; John J Priatel; Melissa C Ma; M Jill Miners; Hung-Sia Teh; Mark A Goldsmith; Ninan Abraham
Journal:  J Exp Med       Date:  2007-02-26       Impact factor: 14.307

9.  Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.

Authors:  Louise M Treanor; Sheng Zhou; Laura Janke; Michelle L Churchman; Zhijun Ma; Taihe Lu; Shann-Ching Chen; Charles G Mullighan; Brian P Sorrentino
Journal:  J Exp Med       Date:  2014-03-31       Impact factor: 14.307

10.  Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic P-selectin/CCL25.

Authors:  Klaus Gossens; Silvia Naus; Stephane Y Corbel; Shujun Lin; Fabio M V Rossi; Jürgen Kast; Hermann J Ziltener
Journal:  J Exp Med       Date:  2009-03-16       Impact factor: 14.307

View more
  4 in total

1.  Breast milk interleukin-7 and thymic gland development in infancy.

Authors:  Elham M Hossny; Dalia H El-Ghoneimy; Rasha H El-Owaidy; Mohamed G Mansour; Mohammad T Hamza; Amira F El-Said
Journal:  Eur J Nutr       Date:  2019-01-03       Impact factor: 5.614

Review 2.  Interleukin-7 Receptor Alpha in Innate Lymphoid Cells: More Than a Marker.

Authors:  Abdalla Sheikh; Ninan Abraham
Journal:  Front Immunol       Date:  2019-12-11       Impact factor: 7.561

3.  Selective dependence on IL-7 for antigen-specific CD8 T cell responses during airway influenza infection.

Authors:  Abdalla Sheikh; Jennie Jackson; Hanjoo Brian Shim; Clement Yau; Jung Hee Seo; Ninan Abraham
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.996

Review 4.  Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis.

Authors:  Deng Chen; Ting-Xuan Tang; Hai Deng; Xiang-Ping Yang; Zhao-Hui Tang
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.